Related Experiment Video
Updated: Apr 23, 2026

07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
20.2K
The cancer stem cell hypothesis: a guide to potential molecular targets
Alessandro Allegra1, Andrea Alonci, Giuseppa Penna
1Division of Hematology, University of Messina , Messina , Italy.
Cancer Investigation
|September 26, 2014
Summary
Cancer Stem Cells (CSCs) may explain tumor growth, spread, and relapse, challenging traditional mutation theories. Targeting CSCs offers a promising new avenue for effective cancer treatment strategies.
Area of Science:
- Oncology
- Cancer Biology
- Stem Cell Research
Background:
- Traditional cancer theories focus on somatic cell mutations driving uncontrolled proliferation.
- Contradictions exist within the mutation theory, suggesting alternative explanations for tumor behavior.
- Cancer Stem Cells (CSCs) are implicated in tumor initiation, maintenance, metastasis, and recurrence.
Purpose of the Study:
- To review the current understanding of Cancer Stem Cells (CSCs).
- To explore the identification of specific CSC markers.
- To discuss the clinical potential of targeting CSCs in cancer therapy.
Main Methods:
- Literature review of existing research on Cancer Stem Cells.
- Analysis of studies focusing on CSC marker identification.
- Discussion of therapeutic strategies targeting CSCs.
Main Results:
- CSCs play a critical role in tumor development and progression.
- Specific markers for CSC identification are being actively researched.
- Targeting CSCs presents a viable strategy for cancer treatment.
Conclusions:
- CSCs offer a unifying explanation for various aspects of tumor biology.
- Further research into CSC markers is crucial for clinical applications.
- Targeting CSCs holds significant promise for improving cancer patient outcomes.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance
2.0K
2.0K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies
1.4K
1.4K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K

